Cytokinetics, Incorporated - Common Stock (CYTK)
60.64
+3.67 (6.44%)
NASDAQ · Last Trade: Oct 7th, 1:49 AM EDT
Detailed Quote
Previous Close | 56.97 |
---|---|
Open | 57.87 |
Bid | 58.89 |
Ask | 63.80 |
Day's Range | 57.28 - 61.00 |
52 Week Range | 29.31 - 61.00 |
Volume | 3,239,765 |
Market Cap | 5.80B |
PE Ratio (TTM) | -11.89 |
EPS (TTM) | -5.1 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 2,567,287 |
Chart
About Cytokinetics, Incorporated - Common Stock (CYTK)
Cytokinetics is a biotechnology company that focuses on the development of novel muscle therapeutics. The company is dedicated to discovering and advancing treatments for a range of diseases characterized by muscle weakness and impaired muscle function, notably in conditions such as heart failure and neuromuscular diseases. Cytokinetics utilizes its expertise in muscle biology to create innovative therapies that may enhance muscle performance, improve patient outcomes, and ultimately transform the standard of care in these areas. Through rigorous research and clinical trials, Cytokinetics aims to provide groundbreaking options for patients with unmet medical needs tied to muscle-related disorders. Read More
News & Press Releases
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 6, 2025
NEW YORK - October 6, 2025 ( NEWMEDIAWIRE ) - Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cytokinetics, Incorporated (“Cytokinetics” or “the Company”) (NASDAQ: CYTK) and certain of its officers.
Via TheNewswire.com · October 6, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 6, 2025
NEW YORK - October 6, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated (NASDAQ: CYTK) of a class action securities lawsuit.
Via TheNewswire.com · October 6, 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · October 5, 2025
NEW YORK, Oct. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of V.F. Corporation (NYSE:VFC), Cytokinetics, Incorporated (NASDAQ:CYTK), Quanex Building Products Corporation (NYSE:NX), and RCI Hospitality Holdings, Inc. (NASDAQ:RICK). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · October 4, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 3, 2025
NEW YORK - October 3, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated (NASDAQ: CYTK) of a class action securities lawsuit.
Via TheNewswire.com · October 3, 2025
NEW ORLEANS, Oct. 01, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cytokinetics, Incorporated (NasdaqGS: CYTK), if they purchased or otherwise acquired the Company’s securities between December 27, 2023 and May 6, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
By SkyMedia, LLC · Via GlobeNewswire · October 1, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 1, 2025
NEW YORK - October 1, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated (NASDAQ: CYTK) of a class action securities lawsuit.
Via TheNewswire.com · October 1, 2025
Via Benzinga · October 1, 2025
NEW YORK CITY and NEW ORLEANS, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cytokinetics, Incorporated (NasdaqGS: CYTK), if they purchased or otherwise acquired the Company’s securities between December 27, 2023 and May 6, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
By Kahn Swick & Foti, LLC · Via GlobeNewswire · September 30, 2025
NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of V.F. Corporation (NYSE:VFC), Cytokinetics, Incorporated (NASDAQ:CYTK), Quanex Building Products Corporation (NYSE:NX), and RCI Hospitality Holdings, Inc. (NASDAQ:RICK). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · September 30, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · September 30, 2025
NEW YORK - September 30, 2025 ( NEWMEDIAWIRE ) - Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cytokinetics, Incorporated (“Cytokinetics” or “the Company”) (NASDAQ: CYTK) and certain of its officers.
Via TheNewswire.com · September 30, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · September 30, 2025
NEW YORK - September 30, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated (NASDAQ: CYTK) of a class action securities lawsuit.
Via TheNewswire.com · September 30, 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · September 30, 2025
NEW YORK - September 29, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated (NASDAQ: CYTK) of a class action securities lawsuit.
Via TheNewswire.com · September 29, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · September 29, 2025
NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · September 28, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · September 26, 2025
NEW YORK - September 26, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated (NASDAQ: CYTK) of a class action securities lawsuit.
Via TheNewswire.com · September 26, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · September 25, 2025